Our previous study showed an important association between ABCC2 rs717620 genotype and methotrexate efficacy in psoriasis, whereby variant allele carriers were more likely to achieve adequate disease control with methotrexate [24], possibly due to this increased methotrexate exposure. The gene discussed is ABCC2; the disease is psoriasis.